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Angela Schulz1*
1 Molecular Biochemistry, Rudolf-Schönheimer-Institute of Biochemistry, Medical Faculty, University of
Leipzig, Leipzig, Germany, 2 Institute of Medical Physics and Biophysics, Medical Faculty, University of
Leipzig, Leipzig, Germany, 3 Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics,
Medical Faculty, University of Leipzig, Leipzig, Germany, 4 Institute of Laboratory Medicine, Ludwig
Maximilians University Munich, Munich, Germany, 5 Institute of Anatomy, Medical Faculty, University of
Leipzig, Leipzig, Germany
☯ These authors contributed equally to this work.
* schoberg@medizin.uni-leipzig.de (TS); angela.schulz@medizin.uni-leipzig.de (AS)
Abstract
Dysfunction of the melanocortin system can result in severe obesity accompanied with dysli-
pidemia and symptoms of the metabolic syndrome but the effect on vascular atherogenesis
is not known. To study the impact of obesity and dyslipidemia on the cardiovascular system,
we generated mice double-deficient for the melanocortin type 4 receptor (Mc4rmut mice) and
the LDL receptor (Ldlr-/- mice). Mc4rmut mice develop obesity due to hyperphagia. Double-
mutant mice (Mc4rmut;Ldlr-/-) exhibited massive increases in body weight, plasma choles-
terol and triacylglycerol levels and developed atherosclerosis. Atherosclerotic lesion size
was affected throughout the aortic root and brachiocephalic artery not only under semisyn-
thetic, cholesterol-containing diet but also under cholesterol-free standard chow. The
Mc4rmut mice developed a hepatic steatosis which contributes to increased plasma choles-
terol levels even under cholesterol-free standard chow. Transcripts of cholesterol biosynthe-
sis components and liver cholesterol levels did not significantly differ between wild-type and
all mutant mouse strains but RNA sequencing data and biochemical measurements point to
an altered bile acid elimination in Mc4rmut;Ldlr-/-. Therefore, the unchanged endogenous
cholesterol biosynthesis together with a reduced hepatic VLDL and LDL-cholesterol clear-
ance most likely led to increased plasma lipid levels and consequently to atherosclerosis in
this animal model. Our data indicate that dysfunction of the melanocortin-regulated food
intake and the resulting obesity significantly add to the proatherogenic lipoprotein profile
caused by LDL receptor deficiency and, therefore, can be regarded as relevant risk factor
for atherosclerosis.
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Introduction
Obesity is a global epidemic with significant morbidity and mortality affecting both adults and
children. Insulin resistance, dyslipidemia and hypertension are often found in obese patients.
This symptom complex is referred to as the metabolic syndrome [1] which increases the risk
of diabetes and cardiovascular diseases [2]. The dyslipidemia that develops in obese humans is
often characterized by elevated triacylglycerol levels, low levels of high-density lipoprotein and
the appearance of small, dense low-density lipoproteins, a combination referred to as
proatherogenic lipoprotein profile or "lipid triad". Although the association between obesity
and dyslipidemia is well established, the mechanism by which obesity contributes to elevations
of plasma lipids is not completely understood [3].
Mouse models are widely used to study obesity, the metabolic syndrome, dysfunctions of
the lipid metabolism, and atherosclerosis. However, animal models that encompass all of these
characteristics remain limited. Mouse strains deficient for apolipoprotein E (apoE) [4] and the
low-density lipoprotein receptor (Ldlr) [5] have been broadly used as models for atherosclero-
sis. For example, mice deficient for the Ldlr (Ldlr-/- mice) have high levels of low-density lipo-
protein (LDL) and can develop massive atherosclerotic lesions depending on the diet [6]. Most
importantly, Ldlr-/- mice are models for hyperlipidemia and atherosclerosis but the effect of a
metabolic syndrome cannot be addressed along with lipid disorders in this model.
The hypothalamus coordinates extra-hypothalamic regions to maintain energy homeo-
stasis through the regulation of food intake and energy expenditure. A number of anorexi-
genic and orexigenic molecules in the hypothalamic nuclei participate in the control of
energy homeostasis among them the proopiomelanocortin-derived melanocyte-stimulating
hormones and their receptors, specifically the melanocortin receptors Mc3r and Mc4r [7]. In
humans, loss-of-function mutations in Mc4r are associated with hyperphagia, severe early-
onset obesity, increased longitudinal growth, fasting hyperinsulinemia, and increased lean
mass [8–10], a phenotype that closely mirrors that seen in Mc4r-deficient mice [11], sup-
porting an essential role for the melanocortin system in energy homeostasis across mamma-
lian species [12]. Mutations in Mc4r are the most frequent monogenic cause of severe early-
onset obesity in humans [13]. It has been demonstrated that the level of central nervous
Mc4r activity potently and rapidly determines the balance among cellular glucose uptake,
triacylglycerol synthesis, lipid deposition, and lipid mobilization in liver, muscle, and adi-
pose tissue [14].
Several mouse strains have been established to investigate the impact of obesity on athero-
sclerosis. Most studies combine apoE or Ldlr deficiency with alterations of the leptin system
[15–20]. There is increasing experimental evidence that leptin and the leptin receptor have
specific effects on the development of atherosclerosis [17]. Although the leptin and melanocor-
tin systems are tightly linked, we asked the question of whether obesity induced by defects in
the melanocortin system has similar effects on the development of atherosclerosis. To mimic
most closely the human defects in the melanocortin type-4 receptor, we bred mice carrying a
partial loss-of-function missense mutation in the Mc4r [21] with Ldlr-/- mice [5]. The double-
mutant mice were used to study the contribution of the melanocortin system to dyslipidemia
and atherosclerosis depending on the alimentary cholesterol content [5, 22]. We found that
the double-mutant mice developed dyslipidemia and atherosclerosis. This mouse model shows
that obesity caused by Mc4r deficiency can promote atherosclerosis already under cholesterol-
free chow. Hepatic RNA sequencing and biochemical data suggest that hepatosteatosis and
altered bile acid elimination contribute to the proatherogenic lipoprotein profile and conse-
quently lead to the formation of atherosclerotic lesions.
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Materials and Methods
Mouse strains and genotyping
Using the chemical random mutagenesis technique with the germline supermutagen N-ethyl-
N-nitrosourea (ENU), a mouse model for mutant Mc4r was generated by Ingenium Pharma-
ceuticals AG, Martinsried, Germany. Functional in vitro analysis of the mouse Mc4r contain-
ing the mutation Ile194Phe revealed a partial loss of receptor function (~40-fold reduced
agonist potency). At the in vivo level, this mutant causes the same full obese phenotype as
observed in a mouse strain containing a Mc4r mutation (Tyr302Cys) with a complete loss-of-
function in in vitro assays [21]. We used the Ile194Phe mouse strain (referred to as Mc4rmut) to
closely mimic the Mc4r dysfunction most frequently found in humans with inhered obesity
[23]. Mice were bred and maintained under specific-pathogen-free conditions at the central-
ised animal care facility, where lights were automatically controlled (12 h light/12 h dark). All
animal experiments were conducted in accordance with the European Directive 2010/63/EU
on the protection of animals used for scientific purposes and were performed with permission
of the Animal Care and Use Committee (ACUC #TVV 43/07) and the Government of the
State of Saxony, Germany.
The initial Ile194Phe C3HeB/FeJ (C3H) mouse strain [21] was crossed into the C57BL/6J
(B6) background over more than 12 generations. Breeding for experiments was performed
with heterozygous breeding pairs. Genotyping of the littermates was performed by polymerase
chain reaction (PCR) followed by BspHI (New England Biolabs, Frankfurt, Germany) restric-
tion analysis. The following primers and PCR conditions were used: 5’- taccctgttaaacagtacgga-
tac-3’ (sense) and 5’- gaacatggaaatgaggcagatca-3’ (antisense) creating a BspHI-site in Mc4r+/+
sequence, conditions: 94˚C 3 min; 35 cycles of 94˚C 30 sec, 58˚C 30 sec and 72˚C 1 min. Prod-
ucts were digested with BspHI and fragments were separated in a 3% agarose gel.
We analyzed groups of Mc4r+/+ and Mc4rmut mice of both genders on standard chow diet
and a semisynthetic diet containing 0.02% cholesterol (Ssniff GmbH, Soest, Germany) [24] (S1
Table). Furthermore, Mc4rmut mice were crossed onto a homozygous B6.Ldlr-/- background
(The Jackson Laboratory, Bar Harbor, Maine, stock no. 002207) to generate double-deficient
mice. These (Mc4rmut;Ldlr-/-) and the respective control (Ldlr-/-) of both genders were weaned
at 3 weeks of age and fed standard chow or semisynthetic diet until they were euthanized after
180 days of age. For euthanasia, mice were deeply narcotized by i.p. injection with a 100 μl mix-
ture of 100 mg/kg body weight ketamine and 5 mg/kg body weight xylazine. Blood was col-
lected post-euthanasia by heart puncture into syringes containing EDTA and the circulatory
system was flushed with PBS (20 ml). Tissues (heart and brachiocephalic artery (BCA)) were
collected from sacrificed mice and snap-frozen in Tissue-tek OCT compound (Sakura
Finetek).
Blood chemistry and histology
Enzymes, lipids and glucose were analyzed in serum and whole blood, according to the guide-
lines of the German Society of Clinical Chemistry and Laboratory Medicine, using a Hitachi
PPEModular analyzer and an Accu-Check1 blood glucose measurement device (both Roche
Diagnostics, Mannheim, Germany), respectively. Lipoproteins were isolated by sequential
ultracentrifugation from 60 μl of plasma at densities (d) < 1.006 g/ml (very low–density lipo-
protein), 1.006 d 1.063 g/ml (intermediate-density lipoprotein and low-density lipopro-
tein), and d> 1.063 g/ml (high-density lipoprotein) in an LE-80K ultracentrifuge (Beckman)
as described [25].
Atherosclerosis quantification in the aortic root and the BCA was performed as previously
described [26]. In brief, the OCT-embedded BCA was sectioned from distal to proximal at
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10 μm thickness. Atherosclerotic lesions luminal to the internal elastic lamina were quantified
in three equidistant oil red O-stained sections 200, 400, and 600 μm from the branching point
of the BCA into the carotid and subclavian arteries. Histomorphological characterization and
computerized morphometric quantification (Zeiss KS300) of the lesions was performed by
two investigators, blinded to the protocol. The mean of the lesion size of the three sections was
used to represent individual atherosclerosis development in the BCA. The aortic root was sec-
tioned from proximal to distal collecting and evaluating 5 sections (each in 50 μm distance).
Lipid extraction
Lipid extraction was conducted according to Folch et al. [27]. Frozen liver tissue (n = 5 per
group, 6-month-old male) was transferred into chloroform/methanol (2:1, v/v) and vortexed
for at least 1 minute. Afterwards, the tissue was sonicated on ice for 1 minute and shaken for 2
h at room temperature and 90 rpm. After shaking, 600 μl 0.9% NaCl solution was added and
samples were vortexed for 1 minute. Phase separation was achieved by 10 minutes of centrifu-
gation at 2,500 rpm. The organic phase was transferred into a new tube and vaporized by vac-
uum centrifugation. Complete cholesterol was determined using the enzymatic Amplex1 Red
Cholesterol Assay Kit (Invitrogen). To determine the amount of extracted cholesterol, the pel-
let was solubilized in 500 μl 1× reaction buffer. A volume of 20 μl of this solution was further
diluted 1:10 in 1× reaction buffer. The reaction was started by adding 50 μl of the diluted
extract to 50 μl master mix which was prepared according to the assay protocol. The solution
was incubated at 37˚C for 30 minutes. Afterwards the samples were excited at 560 nm and
fluorescence intensity was measured with an Infinite1 M200 TECAN Reader at 590 nm.
Intensities were compared to a standard curve and the amount of cholesterol was calculated
per gram of liver tissue.
RNA sequencing of liver transcripts
Total RNA from liver (10 male mice per genotype) was extracted by using the RNeasy Micro
Kit™ (Qiagen, Hilden, Germany) as described in the manufacturer’s instructions. The quantity
of the RNA was measured using a spectrophotometer (Nanodrop ND 1000) and RNA quality
of all samples was examined on the Agilent 2100 bioanalyzer using the RNA 6000 Nano Chip
(Agilent Technologies, Santa Clara, CA). We only included RNA samples with a RIN value
above 8.
Indexed cDNA libraries were generated using TruSeq RNA Sample Preparation Kits v2
(Illumina, San Diego, CA, USA) according to the manufacturer’s protocol, constructing librar-
ies with an average size of 300 bp as evaluated on the Agilent 2100 bioanalyzer with DNA 1000
Chips.
Libraries were sequenced on Illumina HiScanSQ (Core Unit Sequencing, University of
Leipzig), performing ten biological replicates for each genotype. 101 bp raw paired-end reads
were generated on 8 flow cell lanes. Briefly, after quantification of the libraries using the
Library Quantification Kit—Illumina/Universal (KAPABiosystems) according to the instruc-
tions of the manufacturer, products were used for cluster generation. Library DNA at a con-
centration of 10 pM was clustered using an Illumina cBot according to the
PE_Amp_Lin_Block_Hybv8.0 protocol of the manufacturer. Sequencing was performed using
version 3 chemistry and the version 3 flow cell according to the manufacturer’s instructions.
Median cluster density was usually about 600,000 clusters per mm2 or 80–100 million raw clus-
ters per lane.
After intensities call, raw reads were separated according to library indexes allowing up to
one mismatch in the index sequence, but requiring that all bases have a quality score above 15
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(PHRED-scale). After assigning reads to samples we used an in-house-sequencing pipeline to
trim the adapters and to remove low quality reads [28]. Reads were mapped to the reference
mouse genome (July 2007 NCBI37/mm9) with Ensembl v66 annotations using Tophat 2.0.6.
[29, 30] which aligns reads using Bowtie2 (version 2.1.0). Mitochondrial reads and reads
which did not map uniquely to a genome position were excluded. The transcription level for
each gene was obtained by intersecting mapping results with gene annotations using BED-
Tools IntersectBed [31]. Using the DESeq software package [32], differential expression of wt
and KO genes was examined. Only genes that were expressed at least in 10 animals among the
groups were included for analyses. Differentially expressed genes with a nominal p-
value < 0.05 were considered as statistically significant.
Statistical analyses
For analyses of significant differences between the genotypes an unpaired two-tailed Student’s
t-test was used, p-values of< 0.05 were marked ,< 0.01 , and < 0.001 with . To correlate
gender difference in weight gain and body length dependent on the genotypes and diets a
3-way ANOVA was used (S2 Table).
To assess the relationship between the plaque sizes (aortic root, BCA) and the total choles-
terol serum levels a Pearson product-moment correlation coefficient was computed. The
results were summarized in scatterplots and tested for significance.
To test for influence of different parameters on the atherosclerotic plaque size, we run a
multiple regression analysis. We included the serum cholesterol levels, sex, diets, and the Mc4r
deficiency as potential predictors and used the plaque size as response variable. The overall
model including all predictors was highly significant for both, the plaque size in heart and the
BCA (BCA: F(4, 94) = 37.44, p-value < 2.2e




Effects of cholesterol diet and Ldlr deficiency on increases in body
weight and length in Mc4r-deficient mice
Mc4r deficiency led to a significant increase in body weight in male (45%) and female (50%)
mice fed on standard chow and in male (30%) and female (62%) mice on a semisynthetic diet
(Table 1). The body weight differences between Mc4rmut and the other mouse strains were
already obvious after one month after birth (S1 Fig). The difference of weight due to Mc4r defi-
ciency was also found on the Ldlr-/- background (standard chow: male 36%, female 83%; semi-
synthetic diet: male 37%, female 89%). Here, the weight difference between wt female mice
and Mc4rmut;Ldlr-/- females (standard chow: 83%; semisynthetic diet: 89%) was significantly
higher as in Mc4r-deficient females mice (standard chow: 50%; semisynthetic diet 62%). The
Ldlr-/- alone did not significantly influence the body weight in both genders and under the dif-
ferent diets.
In our mouse strain male and female Mc4rmut animals showed a slightly increased body
length of 6% compared to wild-type controls (Table 1). The difference of length between wt
and Mc4rmut was also found on the semisynthetic diet in male (4%) and female (8%) mice. The
difference of length due to Mc4r deficiency was also found on the Ldlr-/- background (standard
chow: male 5%, female 8%; cholesterol diet: male 7%, female 10%).
The gender differences in weight gain and body length depending on the genotypes and
diet were tested using a 3-way ANOVA. It revealed a significant interaction between genotype
and sex (F3, 182 = 5.6579, p< 0.001) which was mainly driven by the differences of females and
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males on the Mc4rmut background. In all cases the differences of body weight and length in
female Mc4rmut were higher than in male Mc4rmut (S2 Table, S2 and S3 Figs).
In summary, Mc4r-deficient mice showed the expected obese phenotype with gender-spe-
cific characteristics. The combination of Mc4r and Ldlr deficiencies had no major impact on
the development of obesity in the Mc4rmut mouse strains.
Dyslipidemia in mice lacking both receptors Mc4r and Ldlr
Next, we addressed the question whether Mc4r deficiency contributes to increases in plasma
lipids in Ldlr-/- mice and, therefore, can be considered as a risk factor of atherosclerosis. As
shown in Fig 1 and Table 2, Mc4r deficiency alone caused small and moderate increases in
plasma cholesterol levels under standard chow and semisynthetic cholesterol-containing diet,
respectively, in both genders. The increase in cholesterol was most pronounced in the LDL
fraction (Table 2). The triglyceride levels remained normal in Mc4rmut on both diets. Essen-
tially similar results were found in a Mc4r gene-deletion mouse strain but the cholesterol con-
tent of the diet was not stated [33].
As shown in Fig 1 and Table 2, the combination of both receptor defects caused massive
increases in plasma cholesterol and triglyceride levels. Importantly, this effect was already seen
under standard chow which did not contain detectable amounts of cholesterol. The cholesterol
and triglyceride levels were higher in male compared to female mice. Significant increases in
lipids were found in all lipoprotein fractions (Table 2).
MC4R-deficient mice develop hepatic steatosis independent of plasma
cholesterol levels
Because cholesterol and triglycerides are mainly produced in the liver, we focused our analysis
on hepatic functional parameters. As shown in Table 3, Mc4rmut mice present significantly ele-
vated activities of ASAT, ALAT, GLDH, and CHE. Interestingly, enzyme activities were fur-
ther increased by semisynthetic diet but not by Ldlr deficiency (see Table 3). Liver morphology
and histology revealed a massive hepatic steatosis without histological signs of inflammation
(see accompanied paper Lede et al.) as already described for Mc4rmut [34, 35]. This non-alco-
holic fatty liver disease (NAFLD) may slowly progress into non-alcoholic steatohepatitis
(NASH), which is characterized by excessive liver inflammation. It has been shown that
Table 1. Body weight and length under standard and cholesterol-containing diets. Body weights and length of the different genotypes were determined
after 184 ± 3 (range 172–194) days after birth. Animals were kept on standard chow or semisynthetic diet containing 0.02% cholesterol. Data are given as
means ± SD. Number of animals are given in parenthesis, and results between groups were tested for significance to the respective Mc4r+/+: *p < 0.05, **
p < 0.01; *** p < 0.001.
male (weight, gram) female (weight, gram)
standard semisynthetic standard semisynthetic
Mc4r+/+;Ldlr+/+ 31.7 ± 3.1 (10) 37.7 ± 5.3 (10) 27.4 ± 3.2 (14) 25.8 ± 2.1 (16)
Mc4rmut;Ldlr+/+ 46.0 ± 5.1 (10)*** 48.9 ± 3.5 (13)*** 41.2 ± 6.6 (11)*** 41.9 ± 3.8 (11)***
Mc4r+/+;Ldlr-/- 32.2 ± 2.6 (17) 37.3 ± 4.4 (16) 23.3 ± 1.4 (15) 25.3 ± 2.2 (18)
Mc4rmut;Ldlr-/- 43.9 ± 8.1 (15)*** 51.3 ± 3.8 (16)*** 42.7 ± 5.6 (15)*** 47.9 ± 6.9 (14)***
male (length, cm) female (length, cm)
standard semisynthetic standard semisynthetic
Mc4r+/+;Ldlr+/+ 9.6 ± 0.6 (10) 10.0 ± 0.3 (14) 9.6 ± 0.6 (12) 9.4 ± 0.3 (13)
Mc4rmut;Ldlr+/+ 10.2 ± 0.3 (10)** 10.4 ± 0.3 (9)* 10.2 ± 0.3 (11)*** 10.2 ± 0.2 (11)***
Mc4r+/+;Ldlr-/- 9.7 ± 0.4 (17) 9.7 ± 0.3 (14) 9.1 ± 0.3 (13) 9.1 ± 0.4 (18)
Mc4rmut;Ldlr-/- 10.2 ± 0.3 (15)** 10.4 ± 0.3 (16)*** 9.8 ± 0.4 (14)*** 10.0 ± 0.3 (14)***
doi:10.1371/journal.pone.0167888.t001
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cholesterol is an important risk factor for the progression to hepatic inflammation in diet-
induced NASH [36].
Mc4rmut mice develop a late-onset hyperglycemia [11] and normal basal blood glucose lev-
els but increased insulin levels and hepatic insulin resistance have been reported [37, 38]. We
found no significant effects on basal blood glucose levels in all genotypes under the two diets
(Table 3). Interestingly, there were no significant differences in liver cholesterol between the
mouse strains and both diets (Table 2) and no significant correlation between the liver choles-
terol and the serum cholesterol concentrations.
Severe atherosclerosis in mice lacking both Mc4r and Ldlr
We analyzed atherosclerotic plaque formation in the aortic root and the BCA as pathomorpho-
logical readout for atherosclerosis in our mouse strains. No atheromata were found in mice
with an Ldlr+/+ genotype regardless of the diet. Although significantly elevated cholesterol lev-
els (up to 4 mmol/L in Mc4rmut on the semisynthetic diet) and obesity Mc4rmut mice did not
develop atherosclerotic plaques. However, the combination of both receptor defects signifi-
cantly increased atheroma formation compared to the atherosclerosis found in Ldlr-/- mice
(Figs 2, 3 and S5). Strikingly, atherosclerotic plaque formation was already found in Mc4rmut;
Ldlr-/- on standard chow as quantified in histological sections stained with Sudan red (Fig 3).
Staining of aortic root sections with an anti-CD68 antibody, a marker expressed in macro-
phages, revealed macrophage-positive plaque formation in female Mc4r+/+;Ldlr-/- and Mc4rmut;
Ldlr-/- mice of both gender (S6 Fig). Quantitative PCR analysis of the macrophage chemoat-
tractant protein MCP1 (CCL2) showed detectable MCP1 expression in male mice on an Ldlr-/-
Fig 1. Severe hypercholesterolemia and hypertriglyceridemia in mice lacking both MC4 and LDL receptors. Serum cholesterol (A) and serum
triglycerides (B) were determined in the indicated mouse strains (n = 10–14 male mice). Female mice show essentially similar results (see Table 2). The
statistic evaluation is given in Table 2.
doi:10.1371/journal.pone.0167888.g001
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background, whereas MCP1 was detectable in all female groups (S7 Fig) with significant
increases in atherosclerotic animals. TNF-α expression was found in aortic roots of semisyn-
thetic fed mice (S7 Fig).
To examine the relationship between plasma cholesterol levels and the atherosclerotic pla-
que size, we run a multiple regression analysis. Thus, we included the serum cholesterol levels,
sex, diets and the Mc4r deficiency as potential predictors and used the plaque size as response
variable. The overall model including all predictors was highly significant for both, the plaque
size in the aortic root and BCA (BCA: F(4, 94) = 37.44, p-value < 2.2e-16 r2 = 0.60; heart:
Table 2. Plasma lipids and lipoproteins and liver cholesterol on standard chow and semisynthetic diets. Plasma lipids and liver cholesterol content
of the different genotypes were determined after 184 ± 3 days after birth. Animals were kept on standard chow and semisynthetic diet. Data are given as
means ± SD and tested for significance to the respective Mc4r+/+: *p < 0.05, ** p < 0.01; *** p < 0.001. The number of animals per group was between 10




















standard chow 1.90 ± 0.33 2.13 ± 0.67* 5.71 ± 2.01 10.74 ± 3.81*** 1.49 ± 0.27 2.04 ± 0.39** 5.11 ± 1.04 7.90 ± 2.39***
semisynthetic diet 2.87 ± 1.06 4.64 ± 1.34*** 20.17 ± 11.30 35.54 ± 14.05** 1.80 ± 0.42 2.44 ± 0.51** 15.72 ± 6.47 30.36 ± 12.06***
VLDL cholesterol (mmol/
L)
standard chow 0.16 ± 0.06 0.11 ± 0.09 0.53 ± 0.25 1.92 ± 1.46** 0.11 ± 0.07 0.09 ± 0.06 0.53 ± 0.58 1.48 ± 0.92**
semisynthetic diet 0.11 ± 0.09 0.17 ± 0.11 4.34 ± 3.23 9.83 ± 4.32*** 0.08 ± 0.06 0.08 ± 0.07 4.69 ± 3.25 7.62 ± 4.60
LDL cholesterol (mmol/
L)
standard chow 0.65 ± 0.14 0.91 ± 0.34*** 3.66 ± 1.65 8.13 ± 3.00*** 0.58 ± 0.13 0.83 ± 0.19** 3.67 ± 0.85 6.11 ± 2.12**
semisynthetic diet 1.30 ± 0.58 2.08 ± 0.77** 14.11 ± 5.86 23.11 ± 5.89*** 0.74 ± 0.40 0.98 ± 0.30 10.40 ± 4.21 18.53 ± 6.91**
HDL cholesterol (mmol/
L)
standard chow 1.18 ± 0.23 1.21 ± 0.35 1.43 ± 0.40 1.40 ± 0.48 0.90 ± 0.16 1.16 ± 0.12*** 1.14 ± 0.37 1.40 ± 1.46
semisynthetic diet 1.65 ± 0.59 2.75 ± 1.35* 1.67 ± 0.50 2.00 ± 0.60 1.06 ± 0.22 1.38 ± 0.26** 1.17 ± 0.38 1.57 ± 0.32**
plasma triglyceride
(mmol/L)
standard chow 0.92 ± 0.23 1.11 ± 0.88 1.38 ± 0.60 3.44 ± 2.15** 0.58 ± 0.16 0.54 ± 0.17 1.14 ± 0.61 2.33 ± 1.29**
semisynthetic diet 0.53 ± 0.19 0.43 ± 0.08 4.72 ± 4.44 9.08 ± 4.61** 0.47 ± 0.10 0.37 ± 0.11* 2.74 ± 1.46 6.37 ± 3.04***
VLDL triglyceride (mmol/
L)
standard chow 0.63 ± 0.29 0.27 ± 0.25* 0.65 ± 0.32 2.63 ± 2.22** 0.28 ± 0.16 0.17 ± 0.10 0.45 ± 0.36 1.58 ± 1.44**
semisynthetic diet 0.22 ± 0.18 0.15 ± 0.09 3.22 ± 1.98 5.51 ± 1.91** 0.17 ± 0.08 0.15 ± 0.07 1.72 ± 1.13 3.49 ± 2.21*
LDL triglyceride (mmol/
L)
standard chow 0.32 ± 0.09 0.31 ± 0.16 0.61 ± 0.23 1.13 ± 0.53** 0.28 ± 0.14 0.22 ± 0.05 0.50 ± 0.16 0.79 ± 0.34**
semisynthetic diet 0.40 ± 0.25 0.34 ± 0.22 1.23 ± 0.57 2.13 ± 0.82*** 0.37 ± 0.15 0.28 ± 0.10 0.76 ± 0.31 1.36 ± 0.47**
HDL triglyceride (mmol/
L)
standard chow 0.11± 0.06 0.19 ± 0.18 0.13 ± 0.07 0.29 ± 0.20* 0.18 ± 0.15 0.13 ± 0.05 0.17 ± 0.30 0.21 ± 0.17
semisynthetic diet 0.29 ± 0.26 0.33 ± 0.35 0.32 ± 0.33 0.66 ± 0.46* 0.31 ± 0.20 0.19 ± 0.15 0.19 ± 0.13 0.39 ± 0.21**
liver cholesterol (mg/g
liver)
standard chow 0.64 ± 0.15 0.88 ± 0.19 0.67 ± 0.16 0.72 ± 0.34 n.d. n.d. n.d. n.d.
semisynthetic diet 0.85 ± 0.16 0.93 ± 0.24 0.90 ± 0.48 0.61 ± 0.34
doi:10.1371/journal.pone.0167888.t002
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F(4, 81) = 65.09, p-value< 2.2e-16, r2 = 0.75). Only cholesterol levels, diet and sex had a signif-
icant impact whereas the Mc4r deficiency did not reach significance (see S3 Table).
Transcriptional changes in cholesterol and bile acid syntheses
As stated above, no differences in liver cholesterol levels were observed between the mouse
strains. To further substantiate this finding, we analyzed the transcript levels of components
relevant for cholesterol and bile acid biosynthesis by RNA-Seq technology. Approximately 30
million reads per animal (10 animals per genotype) were analyzed. Interestingly, the number
of Ldlr transcripts was significantly increased in all Ldlr-/- strains (Table 4). Detailed analysis
revealed that all transcripts mapped to exons 1–4 of the Ldlr whereas Ldlr transcripts of wt
mice were almost equally distributed over all exons. Comparison of transcripts mapping only
to exon 1–4 revealed an approximately 10-fold increase in Ldlr-/- strains. The Ldlr-/- mouse
strain was generated by insertion of a neomycin resistance cassette into exon 4 [5]. The tar-
geted allele would encode a truncated non-functional protein that will not bind LDL, and lacks
a membrane spanning segment. Immunoblot analysis of liver membranes detected a truncated
protein in homozygous mutant animals [5]. This nicely fits with the RNA-Seq data and upre-
gulation can be interpreted as a compensatory regulation because of the lack of Ldlr function.
Several studies on mice with hepatic steatosis have shown that several transcription factors
and components of the triacylglycerol metabolism such as PPARγ (Pparg), fatty acid synthe-
tase (Fasn), SREBP-1c (Srebf1) and stearoyl-coenzyme A desaturase 1 (Scd1) are increasingly
expressed in the liver. We confirmed some of them in our mouse strains where Mc4rmut and
Mc4rmut;Ldlr-/- showed significantly higher mRNA levels for PPARγ and stearoyl-coenzyme A
desaturase 1 compared to wild-type animals (Table 4). The transcripts of fatty acid synthetase
Table 3. Blood glucose, serum urea levels, and liver enzymes on standard chow and semisynthetic diets. Enzyme activities of the different genotypes
were determined after 184 ± 3 days after birth. Animals were kept on standard chow and semisynthetic diet. Data are given as means ± SD and tested for sig-



















standard chow 7.2 ± 0.5 7.1 ± 1.2 8.0 ± 2.1 8.4 ± 2.9 6.3 ± 0.6 6.7 ± 1.3 6.8 ± 1.7 7.8 ± 1.3
semisynthetic diet 7.1 ± 1.2 7.1 ± 1.0 7.3 ± 0.9 7.0 ± 0.6 6.5 ± 0.6 7.0 ± 0.9 6.9 ± 0.6 7.2 ± 1.1
urea (mmol/L)
standard chow 9.2 ± 2.2 8.9 ± 2.6 8.6 ± 2.3 8.0 ± 2.4 9.6 ± 1.8 9.3 ± 1.9 7.5 ± 2.3 9.7 ± 2.7*
semisynthetic diet 8.9 ± 1.7 8.3 ± 1.3 7.5 ± 1.8 7.4 ± 1.4 8.3 ± 1.3 9.1 ± 2.0 8.1 ± 2.1 9.5 ± 2.9
ALAT μkat/L
standard chow 0.42 ± 0.09 0.92 ± 0.54** 0.62 ± 0.45 2.17 ± 1.92* 0.54 ± 0.12 1.16 ± 0.66* 0.54 ± 0.25 0.86 ± 0.63
semisynthetic diet 1.50 ± 1.44 5.28 ± 3.05** 1.60 ± 1.22 6.07 ± 2.98*** 0.67 ± 0.32 3.04 ± 1.79*** 0.78 ± 0.36 3.56 ± 1.55***
ASAT μkat/L
standard chow 1.65 ± 0.71 1.87 ± 0.58 2.37 ± 1.04 3.73 ± 3.36 2.95 ± 1.66 2.41 ± 1.04 2.16 ± 1.26 2.75 ± 1.35
semisynthetic diet 3.38 ± 2.50 6.75 ± 4.16* 3.66 ± 1.82 7.09 ± 3.47* 3.65 ± 2.28 6.55 ± 2.95* 2.85 ± 1.08 6.37 ± 1.81***
CHE μkat/L
standard chow 78.8 ± 7.66 103.9 ± 31.7*** 84.2 ± 15.1 124.4 ± 20.0*** 113.5 ± 11.0 135.0 ± 17.7** 114.3 ± 12.4 119.2 ± 21.7
semisynthetic diet 105.7 ± 22.8 165.2 ± 26.7*** 124.4 ± 26.0 128.8 ± 28.7*** 133.8 ± 18.1 171.3 ± 20.1*** 145.2 ± 19.1 190.8 ± 38.0***
GLDH μkat/L
standard chow 0.13 ± 0.06 0.30 ± 0.24* 0.22 ± 0.19 1.30 ± 1.39* 0.13 ± 0.06 0.69 ± 0.58* 0.12 ± 0.04 0.40 ± 0.05*
semisynthetic diet 0.54 ± 0.35 2.07 ± 0.97*** 0.76 ± 0.72 2.52 ± 1.06*** 0.27 ± 0.18 1.05 ± 0.75** 0.31 ± 0.24 1.92 ± 1.14***
doi:10.1371/journal.pone.0167888.t003
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Fig 2. Atherosclerosis in the aortic root in mice lacking Ldlr and Mc4r;Ldlr. Representative sections of the
aortic root prepared from the different mouse strains. Depicted are sections of the aortic root of female and male
Mc4rmut and Mc4rmut;Ldlr-/- mouse strains fed a chow and semisynthetic diet (0.02% cholesterol).
doi:10.1371/journal.pone.0167888.g002
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and SREBP-1c were higher in those mouse strains but values reached no significance. The
detailed analysis of the complete liver transcriptome data under the different diets and changes
in liver lipid compositions is presented in the accompanied manuscript Lede et. al.,).
In congruence with unchanged hepatic cholesterol we found no evidence for significant
changes in components of the cholesterol biosynthesis (Table 4). Only the mevalonate kinase
(Mvk), 3-ketosteroid reductase (Hsd17b7) and sterol-C4-methyl oxidase (Sc4mol) in double
KO showed significant reduction in transcript expression levels. However, the transcript level
of the rate-limiting enzyme of the cholesterol biosynthesis, the HMG-CoA reductase (Hmgcr),
remained unchanged.
The synthesis of primary bile acids from cholesterol occurs via two pathways: the classic
neutral pathway involving cholesterol 7-alpha-hydroxylase (Cyp7a1), and the acidic path-
way involving a distinct microsomal oxysterol 7-alpha-hydroxylase (Cyp7b1). Transcrip-
tome analysis revealed a significant reduction of Cyp7b1 in all mutant mice compared to wt
mice (Table 4). Also, Cyp7a1 transcript was in general lower in all mutant mice livers but
did not reach significance. Interestingly, the bile acid transporter Slco1a1 was significantly
downregulated in all Mc4rmut strains (Table 4). To evaluate if changes in transcript levels of
these enzymes result in differences of bile acid production, we analysed the bile acid con-
tent of the liver and of bile collected from the gall bladder. We found reduced (but not sig-
nificant) bile acid concentrations in the liver of the Mc4rmut;Ldlr-/- compared to WT
animals (S4A Fig). As shown in S4B Fig, comparison between Mc4rmut and Mc4r+/+ groups,
Fig 3. Quantification of atherosclerotic lesions at the aortic root and brachiocephalic artery (BCA). Male and female mice (wt: +/+, Mc4r
deficiency: mut), all on an Ldlr-deficient background, were fed with standard chow and semisynthetic diet. Atherosclerosis quantification in the BCA
(A) and the aortic root (B) was performed after 6 months as previously described (14). Data of the indicated genotypes are given as a scatter and
box plot showing the median (bold line) and the lower and the upper quartile (as box) (7–15 animals per group; from left to right: n = 11, 12, 11, 13, 13,
12, 15, 12, 10, 11, 7, 12, 13, 8, 14, 11).
doi:10.1371/journal.pone.0167888.g003
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showed no significant differences in bile acids in the collected bile (p = 0.38, WT vs.
Mc4rmut; p = 0.28, Ldlr-/- vs. Mc4rmut;Ldlr-/-). However, significant lower bile acid levels
where found in the Ldlr-/- and Mc4rmut;Ldlr-/- strains when compared to WT animals
(p = 0.037; p = 0.012).
Table 4. Transcriptional changes of selected components of the cholesterol and bile acid biosyntheses. RNA sequencing was performed with RNA
from livers of 10 animals of each genotype. Means of the expression ratio (KO/WT) for each gene are listed. For p-value calculations an unpaired two-tailed
Student’s t-test was used.
WT vs Mc4rmut WT vs Ldlr-/- WT vs Mc4rmut;Ldlr-/- Ldlr-/- vs Mc4rmut;Ldlr-/-
transcript fold change WT—KO p-value fold change WT—KO p-value fold change WT—KO p-value fold change WT—KO p-value
Ldlr 1.33 0.12 3.31 0.001 3.49 0.001 1.05 0.609
Srebf1 1.37 0.43 0.86 0.428 1.1 0.634 1.27 0.092
Srebf2 0.37 0.068 0.31 0.066 0.3 0.034 0.94 0.44
Scd1 2.41 0.005 1.39 0.377 2.19 0.024 1.56 0.053
Fasn 2.29 0.195 0.96 0.421 1.74 0.256 1.8 0.025
Ppara 1.16 0.576 0.96 0.253 1.14 0.971 1.18 0.197
Pparg 2.35 0.001 0.92 0.784 2.13 0.001 2.3 0.001
Cholesterol biosynthesis
Cyp51 0.87 0.085 0.92 0.464 0.73 0.051 0.79 0.133
Dhcr24 1.58 0.003 1.05 0.49 1.28 0.112 1.21 0.275
Dhcr7 1.07 0.871 0.9 0.807 0.87 0.437 0.96 0.475
Hmgcr 1.1 0.822 0.87 0.799 0.88 0.956 1.01 1
Hmgcs2 1.32 0.064 1.03 0.5 1.3 0.34 1.25 0.122
Fdft1 1.16 0.666 0.95 0.887 0.87 0.621 0.91 0.396
Hsd17b7 0.89 0.116 0.78 0.026 0.75 0.028 0.96 0.766
Lss 1.05 0.532 0.91 0.649 0.91 0.557 1 0.771
Mvk 0.85 0.274 0.72 0.06 0.55 0.012 0.77 0.105
Nsdhl 0.97 0.318 0.92 0.509 0.85 0.19 0.91 0.433
Sc4mol 0.78 0.052 0.87 0.461 0.66 0.025 0.76 0.053
Sqle 0.94 0.334 1.09 0.257 0.8 0.239 0.73 0.027
Tm7sf2 1.07 1 1.01 0.796 0.94 0.546 0.93 0.705
Bile Acid biosynthesis
Acot8 1.36 0.029 1.05 0.655 1.14 0.484 1.08 0.731
Acox2 0.95 0.696 0.98 0.826 0.86 0.342 0.87 0.387
Akr1d1 0.94 0.327 1.23 0.343 1.19 0.238 0.97 0.685
Amacr 0.94 0.898 1.01 0.963 0.87 0.403 0.86 0.323
Baat 0.86 0.187 0.96 0.618 0.77 0.11 0.8 0.187
Cyp27a1 0.95 0.97 0.88 0.506 0.71 0.061 0.8 0.115
Cyp39a1 0.65 0.017 1.04 0.858 0.88 0.469 0.84 0.325
Cyp46a1 4.02 0.019 2.19 0.084 4.45 0.008 2.02 0.058
Cyp7a1 0.69 0.436 0.68 0.615 0.62 0.602 0.91 0.744
Cyp7b1 0.35 0.001 0.53 0.008 0.21 0.001 0.4 0.004
Cyp8b1 1.32 0.03 0.73 0.009 0.94 0.941 1.28 0.038
Hsd17b4 1.21 0.169 0.9 0.205 1.1 0.579 1.22 0.091
Hsd3b7 0.97 0.576 0.92 0.243 0.8 0.155 0.87 0.608
Scp2 1.03 0.797 0.93 0.551 0.87 0.591 0.93 0.849
Scp2-ps2 1.39 0.776 0.73 0.066 1.17 0.398 1.6 0.289
Slco1a1 0.48 0.001 0.81 0.053 0.26 0.001 0.32 0.004
Slc27a5 0.93 0.77 1.03 0.744 0.9 0.554 0.87 0.33
doi:10.1371/journal.pone.0167888.t004
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Discussion
Obesity and the metabolic syndrome are well-established cofactors for the development of ath-
erosclerosis but usually obese mice strains present vascular atheromata only by additional
genetic defects in atherogenic factors (Ldlr, apoE) and cholesterol-containing diets [15–20].
Similarly, Mc4r deficiency leads to obesity but had only small effects on plasma lipid levels (Fig
1, Table 2) and no atherosclerotic plaques were found on standard chow and semisynthetic
diet. However, combination with Ldlr deficiency significantly increased both, plasma triglycer-
ides and cholesterol levels, and double-deficient male mice develop atherosclerosis already on
cholesterol-free standard chow (Fig 3). This is indeed striking since atherosclerotic plaques are
usually absent in atherogenic transgenic mouse strains when fed diets without cholesterol.
Since the development of atherosclerosis correlated with cholesterol levels (Fig 4, S4 Table)
one can consider the cause of atherosclerosis found already under cholesterol-free diet as an
additive effect of both gene defects rather than as an Mc4r-specific, lipid-unrelated mechanism.
This is supported by the multiple regression analysis indicating no significant impact of Mc4r
deficiency itself on plaque size (S3 Table).
It is important to note that the elevated plasma cholesterol levels must have come from
endogenous synthesis in mice on standard chow. However, the cholesterol content of the liver
remained unchanged regardless the diet and genotype (see Table 2). While it is clear that the
Mc4rmut;Ldlr-/- mice have much higher triacylglycerol levels (Table 2), and because there is no
high affinity clearance of apoB lipoproteins, it is either more VLDL secretion or decreased
lipolysis of VLDL triacylglycerol and cholesterol causing the overall increase in lipid levels.
Because decreased lipolysis probably would not increase LDL cholesterol dramatically this is
Fig 4. Correlation between plasma cholesterol levels and plaque sizes of atherosclerotic lesions at the aortic root and brachiocephalic artery
(BCA). Correlations were performed with the data of Table 2 and Fig 3. To illustrate the results of the multiple regression analysis (see Material and
Methods), we plotted the cholesterol levels against the plaque size for males and females. Furthermore, we added a linear regression line computed
separately for Ldlr-/- with and without Mc4rmut (regression coefficients are given in the figure, the respective p-values can be found in S2 Table).
doi:10.1371/journal.pone.0167888.g004
Atherosclerosis and Mc4r Deficiency
PLOS ONE | DOI:10.1371/journal.pone.0167888 December 28, 2016 13 / 18
most likely an obesity-driven increase in VLDL triacylglycerol and cholesterol secretion lead-
ing to the rest of the lipid changes in blood.
In a previous genetic approach the combination of leptin (ob/ob) and Ldlr deficiency lead to
a very similar phenotype [16]. It was speculated that the hypertriglyceridemia and hypercho-
lesterolemia in the double mutant mice were caused by distinct mechanisms and point to the
possibility that leptin might have some impact on plasma cholesterol metabolism, possibly
through an Ldlr-independent pathway. We can rule out this hypothesis in our double mutant
mice because, in contrast to ob/ob mice, Mc4r-deficient mice exhibit very high serum leptin
levels [39]. It is very likely that the hyperphagia-induced obesity in ob/ob and in our Mc4rmut
causes the hypertriglyceridemia. As the obese ob/ob mice, Mc4r-deficient mice and rodents
with a pharmacological blockade of central nervous MC receptors develop an NAFLD proba-
bly due to a hepatic overproduction of triglycerides [14, 16, 34, 38, 40]. Increased expression
levels of factors relevant for hepatic triglyceride metabolism such as SREBP-1c and Fasn were
found in these and our studies (Table 4). Mc4r-deficient mice have hyperinsulinemia [34, 41]
and hyperinsulinemia stimulates expression of lipogenic genes such as SREBP-1c and PPARγ
in liver [42–44]. It has been shown in wt and ob/ob mice that insulin increases hepatic VLDL
secretion. This all is supportive for a scenario in which the high food intake in Mc4rmut mice
increases hepatic triglyceride biosynthesis and VLDL secretion resulting in proatherogenic
plasma lipoprotein profile. This is further supported by the fact that changes in lipid metabo-
lism of Mc4rmut mice mostly explain atherosclerosis. Although specific effects of Mc4r defi-
ciency on atherosclerosis, especially in male mice on Ldlr-/- background (Fig 3), cannot be
completely excluded albeit statistical correlations indicated no significant influence of the
genotype.
Atherosclerosis was seen already under cholesterol-free diet and the question remains what
is the pathomechanism underlying the hypercholesterolemia specifically in the case of the cho-
lesterol-free diet? We and others [16] did not find elevated cholesterol levels in the liver and
RNA-sequencing data did not provide evidence for increased mRNA levels of proteins
involved in cholesterol biosynthesis in Mc4rmut;Ldlr-/-(Table 4). Therefore, hypercholesterol-
emia in Mc4rmut;Ldlr-/- on standard chow is not mainly caused by a hepatic overproduction
but rather a result of the loss of hepatic VLDL and LDL-cholesterol clearance due to Ldlr defi-
ciency. However, the combination of both, Ldlr and Mc4r deficiencies, showed additive effects
on plasma cholesterol levels indicating that NALFD found in Mc4rmut additionally contribute
hypercholesterolemia. Reduced elimination of cholesterol via bile acid biosynthesis and excre-
tion may be one factor. In fact, the most prominent down-regulated components in the liver of
obese ob/ob mice [45] and of our Mc4rmut strains (Table 4) were Cyp7b1 and Slco1a1. A similar
observation was reported from Nagoya-Shibata-Yasuda (NSY) mice which develop type 2 dia-
betes and hepatic steatosis [46]. Transient overexpression of Cyp7b1 and Slco1a1 reduced
weight gain in obese mice and normalized plasma glucose levels [45]. It remains speculative
whether a reduced Cyp7b1 and Slco1a1 expression contributed to the additive effects on
plasma cholesterol levels in double KO mice since Cyp7b1 contributes to only ~5% of total bile
production and Slco1a1 is not the only bile acid transporter in liver. However, measurement
of bile acid concentrations in the gall bladder of the mouse groups support the results from
RNA sequencing, pointing to reduced bile acid elimination in double KO mice (S4 Fig).
In sum, most obese genetic mouse models do not develop an atherosclerosis phenotype
without additional genetic defects combined with cholesterol in their diets. The Mc4rmut;Ldlr-/-
mouse strain is a rare genetic model presenting atherosclerosis already under cholesterol-free
diet. The combination of the hepatic steatosis caused by Mc4r deficiency and a reduced hepatic
VLDL and LDL-cholesterol clearance due to Ldlr deficiency directly correlate with plasma
cholesterol levels and, therefore, with the development of atherosclerosis.
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